Results 11 to 20 of about 28,989 (238)

Management of transthyretin amyloidosis. [PDF]

open access: yesSwiss medical weekly, 2021
Transthyretin amyloidosis (ATTR amyloidosis) is a disease caused by deposition of transthyretin fibrils in organs and tissues, which causes their dysfunction.
Monney, P.   +136 more
core   +4 more sources

Evolution of transthyretin in marsupials [PDF]

open access: yesEuropean Journal of Biochemistry, 1995
The evolution of the expression and the structure of the gene for transthyretin, a thyroxine-binding plasma protein formerly called prealbumin, was studied in three marsupial species: the South American polyprotodont Monodelphis domestica, the Australian
Dziegielewska, KM (15476936)   +11 more
core   +7 more sources

The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis [PDF]

open access: yesFEBS Letters, 1991
A variety of mutations leading to amino acid substitutions have been described in the transthyretin gene in association with different familial amyloidoses and have been implicated to be involved in the pathogenesis of amyloid deposits.
Gustavsson, Å.   +11 more
core   +3 more sources

Computational Studies on Transthyretin

open access: yesCurrent Medicinal Chemistry, 2012
Among the 23 different fibril proteins described in human amyloidosis, transthyretin is associated with the most common hereditary form of the disease and its knowledge is corroborated through about 150 crystal structures in addition to thousands of ...
MARTINELLI, ADRIANO   +1 more
core   +4 more sources

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates

open access: yesInternational Journal of Molecular Sciences, 2023
Transthyretin amyloidosis (ATTR) is a progressive and systemic disease caused by the misfolding and amyloid aggregation of transthyretin (TTR). Stabilizing the TTR tetramers and disrupting the formed TTR aggregation are treated as a promising strategy for the treatment of ATTR.
Huizhen Zou, Shuangyan Zhou
openaire   +2 more sources

Evaluation of the Current ATTR-CM Treatment Landscape via a Mathematical Model of TTR Dissociation and Amyloid Formation. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
ABSTRACT Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a progressive, often fatal disease arising from the dissociation of circulating transthyretin (TTR) tetramers into monomers that misfold and form amyloid fibrils that deposit in the myocardium and other tissues. Approved treatment paradigms involve tetramer stabilization with small molecules or
Methven Jeknić S   +6 more
europepmc   +2 more sources

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Intrahepatic cholangiocarcinoma (ICC) is a deadly but poorly understood disease, and its treatment options are very limited. The aim of this study was to identify the molecular drivers of ICC and search for therapeutic targets.
Yuto Shiode   +16 more
wiley   +1 more source

Proxy markers of serum retinol concentration, used alone and in combination, to assess population vitamin A status in Kenyan children: a cross-sectional study [PDF]

open access: yes, 2015
Background Serum retinol concentration determined by high-performance liquid chromatography (HPLC) is recommended by the World Health Organization to assess population vitamin A status.
Inge D Brouwer   +17 more
core   +1 more source

The negative acute phase response of serum transthyretin following Streptococcus suis infection in the pig [PDF]

open access: yes, 2005
Peer ...
Eckersall, P D   +28 more
core   +1 more source

Evolutionary changes to transthyretin: evolution of transthyretin biosynthesis [PDF]

open access: yesThe FEBS Journal, 2009
Thyroid hormones are involved in growth and development, particularly of the brain. Thus, it is imperative that these hormones get from their site of synthesis to their sites of action throughout the body and the brain. This role is fulfilled by thyroid hormone distributor proteins.
openaire   +2 more sources

Home - About - Disclaimer - Privacy